Moreover, cytokine production in CD4+ T cells from patients with GCA was dependent on the JAK-STAT pathway, as demonstrated by an experiment showing that tofacitinib, an inhibitor of JAK1 and JAK3, inhibited IFN-γ production in a dose-dependent manner (27). The gene discussed is JAK1; the disease is temporal arteritis.